Gilho Lee

Gilho Lee

Auto-generated profile, based on publicly available information

Gilho Lee

Department of Urology, Dankook University College of Medicine, Cheonan, Korea

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Korean Journal of Urology
Verified
Journal Article
Open access
PDF file
GLGilho Lee
Gilho Lee
Urinary tract infection (UTI) is one of the most prevalent bacterial infections, and fluoroquinolone therapy is a well-known standard regimen for UTI. The prevalence and risk factor analysis of fluoroquinolone resistance in enterococcal UTIs are not well documented. The aim of this study was to evaluate the antimicrobial susceptibility and risk factors for ciprofloxacin resistance in Enterococcus faecalis strains isolated from patients with complicated UTI. We evaluated 81 E. faecalis strains isolated from 81 male patients at a single teaching hospital over 3 years. The Vitek 2 automatic system was used for antimicrobial susceptibility analysis. Antimicrobial resistance rates were rare for ampicillin/sulbactam, imipenem, and vancomycin in E. faecalis. Forty-six percent of the E. faecalis strains were resistant to levofloxacin, 47% were resistant to ciprofloxacin, and 58% were resistant to norfloxacin. E. faecalis strains were highly resistant to erythromycin (92%) and ftetracycline (96%). The risk factor analysis revealed that age intervals, the underlying diseases, catheterization, and the number of admissions did not increase the risk of ciprofloxacin resistance, whereas patients with hospital-acquired infection (odds ratio [OR], 18.15; 95% confidence interval [CI], 3.46 to 95.13; p=0.001), patients who were treated in a urological department (OR, 6.15; 95% CI, 1.5 to 25.41; p=0.012), and patients who were transferred from health care centers (OR, 7.393; 95% CI, 1.32 to 41.22; p=0.023) had an increased risk of ciprofloxacin resistance compared with the matched controls. Ciprofloxacin is no longer a recommended therapy for E. faecalis from complicated UTI in men with risk factors. We suggest that ampicillin/sulbactam can be recommended as alternatives for treating ciprofloxacin-resistant E. faecalis strains associated with UTI in Korea.

1 June 2006 in Journal of Infection
Verified
Journal Article
Closed access
GLGilho Lee
Gilho Lee
JPJungae Park
Jungae Park
BKBohram Kim
Bohram Kim
SKSun-A Kim
Sun-A Kim
CYCheon-Kwon Yoo
Cheon-Kwon Yoo
WSWon Keun Seong
Won Keun Seong

1 January 2021 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
YSYumi Seo
Yumi Seo
KCKyung-Hwa Choi
Kyung-Hwa Choi
GLGilho Lee
Gilho Lee
Seo Y, et al. World J Mens Health. 2021 Jan;39(1):107-115. https://doi.org/10.5534/wjmh.190116

1 January 2010 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
GLGilho Lee
Gilho Lee
YCYong-Hyun Cho
Yong-Hyun Cho
BSBong Suk Shim
Bong Suk Shim
SLSang Don Lee
Sang Don Lee
Lee G, et al. J Korean Med Sci. 2010 Aug;25(8):1205-1209. http://dx.doi.org/10.3346/jkms.2010.25.8.1205

1 January 2014 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
EHEu Chang Hwang
Eu Chang Hwang
SJSeung Il Jung
Seung Il Jung
DKDongdeuk Kwon
Dongdeuk Kwon
GLGilho Lee
Gilho Lee
JBJae Hyun Bae
Jae Hyun Bae
ICIn Ho Chang
In Ho Chang
Hwang EC, et al. J Korean Med Sci. 2014 Sep;29(9):1271-1277. https://doi.org/10.3346/jkms.2014.29.9.1271

1 January 2009 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SCSeong Hoo Choi
Seong Hoo Choi
YBYoungmin Byun
Youngmin Byun
GLGilho Lee
Gilho Lee
Choi SH, et al. J Korean Med Sci. 2009 Aug;24(4):684-689. http://dx.doi.org/10.3346/jkms.2009.24.4.684